https://www.live-feeds.com/feed/new-type-of-blood-thinner-approved-to-prevent-repeat-strokesContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/new-type-of-blood-thinner-approved-to-prevent-repeat-strokeshttps://www.live-feeds.com/feed/new-type-of-blood-thinner-approved-to-prevent-repeat-strokes#u200466Sat, 14 Nov 2026 11:55:18 +0000The US Food and Drug Administration has approved a novel blood thinner developed by Bayer to prevent repeat strokes. The medication, asundexian, represents a first-in-class approval in the United States designed to reduce the recurrence of stroke. Industry analysts view the new pharmaceutical as a potential blockbuster treatment in the cardiovascular medicine market. The approval offers patients and medical providers a new therapeutic option aimed at lowering the risk of subsequent strokes, adding to existing treatment strategies for individuals who have previously suffered a cerebrovascular e